Please provide your email address to receive an email when new articles are posted on . Isolated ACL reconstruction had a graft failure rate of 10% vs. 4% in ACL plus anterolateral ligament ...
ABANZA’s QuadLock™ delivers market-leading fixation strength with over a 500% reduction in cyclic displacement compared to conventional fixation methods. QuadLock™ is designed to securely fixate ...
Please provide your email address to receive an email when new articles are posted on . Results showed no significant differences in retear rates between patients with vs. those without tendinopathy.
At second-look arthroscopies, Shino et al [8] detected deterioration of the patellofemoral articular surface. Fifty-one percent were noted to have progressive arthrosis primarily affecting the central ...
ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QuadLock(TM), its new ...